← Back to Search

Topical Analgesic

Capsaicin 8% Patch for Spinal Cord Injury (Capsaicin Trial)

N/A
Waitlist Available
Led By Michelle Trbovich, MD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pain at 2,4,6,8, 10 and 12 weeks
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group

Summary

This trial will study how well and how long 8% capsaicin patches work to relieve neuropathic pain in people with spinal cord injuries.

Eligible Conditions
  • Spinal Cord Injury
  • Nerve pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pain at 2,4,6,8, 10 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in pain at 2,4,6,8, 10 and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Pain Relief With Visual Analog (VAS) Pain Scale
Change in Quality of Life as Measured by the World Health Organization Quality of Life (WHOQOL-BREF)
Spinal Cord

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Investigational Capsacin, Then Control CapsacinExperimental Treatment2 Interventions
Qutenza, Capsaicin 8% Patch will be used for 12 weeks followed by capsacin 0.025% Well Patch
Group II: Control Capsacin, Then Investigational CapsacinExperimental Treatment2 Interventions
Active control with low dose capsaicin 0.025% Well Patch used for 12 weeks followed by Qutenza 8% Patch
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Dose Capsaicin 0.025% Well Patch
2016
N/A
~20
Capsaicin
FDA approved

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
476 Previous Clinical Trials
92,964 Total Patients Enrolled
Michelle Trbovich, MDPrincipal InvestigatorSouth Texas Veterans Health Care System
1 Previous Clinical Trials
20 Total Patients Enrolled
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top